Observational Study of Switching from Natalizumab to Immunomodulatory Drugs

Publisher： Karger

E-ISSN： 1421-9913|77|3-4|130-136

ISSN： 0014-3022

Source： European Neurology, Vol.77, Iss.3-4, 2017-01, pp. : 130-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab and Regulation of Cerebral Blood Flow: Results from an Observational Study

By  

European Neurology, Vol. 64, Iss. 2, 2010-07 ,pp. : 124-128

Karger

Access to resources Recommend Favorite

Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy

By Bellia Alfonso   Babini Anna   Marchetto Paolo   Arsenio Leone   Lauro Davide   Lauro Renato  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite

Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study

By  

European Neurology, Vol. 72, Iss. 3-4, 2014-09 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 265-276

Bentham Science Publishers

Access to resources Recommend Favorite

Amelioration of Small Bowel Injury by Switching from Nonselective Nonsteroidal Anti-Inflammatory Drugs to Celecoxib in Rheumatoid Arthritis Patients: A Pilot Study

By  

Digestion, Vol. 89, Iss. 2, 2014-02 ,pp. : 124-132

Karger

Access to resources Recommend Favorite